Studies immune dysregulation in chronic viral infection, integrating T-cell biology, antiviral gene editing, and biomarker discovery. Uses non-viral CRISPR, latency models, and multi-omics to inform immunotherapies and clinical monitoring across HIV, hepatitis B, EBV, and COVID-19.